{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:06:05Z","timestamp":1789909565387,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd010389","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000}}],"reference-count":98,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010389.pub2","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T18:36:10Z","timestamp":1414866970000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Imiquimod for anogenital warts in non-immunocompromised adults"],"prefix":"10.1002","volume":"2014","author":[{"given":"Carlos F","family":"Grillo-Ardila","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Universidad Nacional de Colombia; Department of Obstetrics & Gynecology and Clinical Research Institute; Carrera 30 No 45-03 Bogota Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Angel-M\u00fcller","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universidad Nacional de Colombia; Department of Obstetrics & Gynecology; Cra 30 # 45-03 Bogota Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis C","family":"Salazar-D\u00edaz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universidad Nacional de Colombia; Clinical Research Institute; Bogota Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernando G","family":"Gait\u00e1n","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universidad Nacional de Colombia; Department of Obstetrics & Gynecology and Clinical Research Institute; Carrera 30 No 45-03 Bogota Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel I","family":"Ruiz-Parra","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universidad Nacional de Colombia; Department of Obstetrics & Gynecology and Clinical Research Institute; Carrera 30 No 45-03 Bogota Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lethaby","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Obstetrics and Gynaecology; Private Bag 92019 Auckland New Zealand 1142"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,11,1]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD010389.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1346-8138.2004.tb00568.x","article-title":"Topical imiquimod 5% cream in external anogenital warts: a randomized, double-blind, placebo-controlled study","volume":"31","author":"Arican","year":"2004","journal-title":"Journal of Dermatology"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"806105","DOI":"10.1155\/2011\/806105","article-title":"Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies","volume":"2011","author":"Baker","year":"2011","journal-title":"Infectious Diseases in Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD010389.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.42.4.789","article-title":"Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts","volume":"42","author":"Beutner","year":"1998","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD010389.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0190-9622(98)70243-9","article-title":"Treatment of genital warts with an immune-response modifier (imiquimod)","volume":"38","author":"Beutner","year":"1998","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD010389.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts","volume":"134","author":"Edwards","year":"1998","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD010389.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/OLQ.0b013e3181f68ebb","article-title":"Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts","volume":"38","author":"Komericki","year":"2011","journal-title":"Sexually Transmitted Diseases"},{"issue":"2","key":"10.1002\/14651858.CD010389.pub2-BIB0007|cit7","first-page":"67","article-title":"A comparative study of efficacy of imiquimod 5% versus podophyllin 20% in treatment of external and genital warts (60 patients)","volume":"27","author":"Padhiar","year":"2006","journal-title":"Indian Journal Of Sexually Transmitted Diseases"},{"issue":"6","key":"10.1002\/14651858.CD010389.pub2-BIB0008|cit8","first-page":"642","article-title":"Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts","volume":"16","author":"Sch\u00f6fer","year":"2006","journal-title":"European Journal of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD010389.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1258\/ijsa.2007.007196","article-title":"Comparison of cryotherapy to imiquimod 5% in the treatment of anogenital warts","volume":"19","author":"Stefanaki","year":"2008","journal-title":"International Journal of STD & AIDS"},{"issue":"2","key":"10.1002\/14651858.CD010389.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/517472","article-title":"A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod","volume":"178","author":"Tyring","year":"1998","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD010389.pub2-BIB0011|cit11","first-page":"337","article-title":"Direct medical costs for surgical and medical treatment of condylomata acuminata","volume":"137","author":"Alam","year":"2001","journal-title":"Archives of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD010389.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2217\/fvl.09.57","article-title":"Topical treatment of anogenital human papillomavirus infection in male patients","volume":"4","author":"Ankerst","year":"2009","journal-title":"Future Virology"},{"issue":"1","key":"10.1002\/14651858.CD010389.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0166-3542(99)00033-9","article-title":"Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%","volume":"43","author":"Arany","year":"1999","journal-title":"Antiviral Research"},{"issue":"2","key":"10.1002\/14651858.CD010389.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.contraception.2010.04.129","article-title":"Imiquimod 2.5% and 3.75% applied daily for up to 8 weeks to treat external genital warts","volume":"82","author":"Baker","year":"2010","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0015|cit15","unstructured":"Beutner K Comparison of the results from two well controlled trials of topical imiquimod for the treatment of genital\/perianal warts (Abstract 52) Journal of Investigative Dermatology 1995 563 563."},{"key":"10.1002\/14651858.CD010389.pub2-BIB0016|cit16","first-page":"682","article-title":"Comparison of two vehicle-controlled trials of imiquimod 5% cream for the treatment of external genital warts (Abstract 1259)","volume":"110","author":"Beutner","year":"1998","journal-title":"Journal of Investigative Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD010389.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0020-7292(02)00034-6","article-title":"Imiquimod 5% cream in the treatment of anogenital warts in female patients","volume":"77","author":"Buck","year":"2002","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"5","key":"10.1002\/14651858.CD010389.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/095646240401500508","article-title":"Patient assessment of anogenital warts and the success of treatment with home applied therapy","volume":"15","author":"Carey","year":"2004","journal-title":"International Journal of STD & AIDS"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD010389.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1067\/mjd.2002.126579","article-title":"Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions","volume":"47","author":"Carrasco","year":"2002","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0020|cit20","unstructured":"Castellsague X Bosch FX Puig Tintore LM Sanjose S de Moreno V Ribes J The 18th International Papillomavirus Conference Program and abstracts book Barcelona 2000 550"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0021|cit21","first-page":"113","article-title":"Vehicle-controlled study investigating the mechanism of action of 5% imiquimod cream applied three times a week for the treatment of patients with genital\/perianal warts. Abstract 1320. The 19th World Congress of Dermatology; 1997 15-20 June; Sydney","volume":"38","author":"Chopra","year":"1997","journal-title":"Australasian Journal of Dermatology"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0022|cit22","unstructured":"Como N Kraja D Qato M Gjermeni N Kica A Duraku K Our experience in treatment of warts in women with Condylin and Aldara International Society for Infectious Diseases 2010 ISE.218"},{"issue":"12","key":"10.1002\/14651858.CD010389.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/archderm.138.12.1599","article-title":"Systematic review of imiquimod for the treatment of genital warts: all that glitters is not gold","volume":"138","author":"Corona","year":"2002","journal-title":"Archives of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010389.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/11594610-000000000-00000","article-title":"Treatment of cutaneous warts: an evidence-based review","volume":"13","author":"Dall'oglio","year":"2012","journal-title":"American Journal of Clinical Dermatology"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0025|cit25","first-page":"AB135","article-title":"Assessment of efficacy, safety, and tolerability of imiquimod cream 5% in adult patients with external genital warts: a first Indian study","volume":"54","author":"Desai","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0026|cit26","doi-asserted-by":"crossref","unstructured":"Edwards L Ferenczy A Eron L Baker D Fox T Gayoso K Multi-center safety and efficacy trial evaluating three times per week application of 1% and 5% topical imiquimod for the treatment of genital\/perianal warts Antiviral Research 1995 A244","DOI":"10.1016\/0166-3542(95)94731-G"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1080\/01443619866606","article-title":"Immune response modifiers: Imiquimod","volume":"18","author":"Ferenczy","year":"1998","journal-title":"Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0028|cit28","doi-asserted-by":"crossref","unstructured":"Ferris D Baker D Tyring S Trofatter K Barry G Levy S Imiquimod 2.5% and 3.75% applied daily for up to 8 weeks to treat external genital warts The 26th International Papillomavirus Conference; 2010 July 3-8 Montreal 2010 Poster (P-544)","DOI":"10.1016\/j.contraception.2010.04.129"},{"issue":"4","key":"10.1002\/14651858.CD010389.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00007435-200104000-00007","article-title":"Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day","volume":"28","author":"Fife","year":"2001","journal-title":"Sexually Transmitted Diseases"},{"issue":"11","key":"10.1002\/14651858.CD010389.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1258\/0956462011924218","article-title":"Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts - results of an open-label, multicenter Phase IIIB trial","volume":"12","author":"Garland","year":"2001","journal-title":"International Journal of STD & AIDS"},{"issue":"7","key":"10.1002\/14651858.CD010389.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1258\/095646206777689161","article-title":"An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women","volume":"17","author":"Garland","year":"2006","journal-title":"International Journal of STD & AIDS"},{"issue":"3","key":"10.1002\/14651858.CD010389.pub2-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001781.pub2","article-title":"Topical treatments for cutaneous warts","author":"Gibbs","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010389.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/095646240101200105","article-title":"Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day","volume":"12","author":"Gollnick","year":"2001","journal-title":"International Journal of STD & AIDS"},{"issue":"4","key":"10.1002\/14651858.CD010389.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/OLQ.0b013e31815ea8d1","article-title":"Optimal frequency of imiquimod (Aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis","volume":"35","author":"Gotovtseva","year":"2008","journal-title":"Sexually Transmitted Diseases"},{"issue":"1","key":"10.1002\/14651858.CD010389.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3923\/ijp.2007.1.10","article-title":"Systematic review of imiquimod for the treatment of external genital wart","volume":"3","author":"Jaffary","year":"2007","journal-title":"International Journal of Pharmacology"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0926-9959(98)94686-4","article-title":"Imiquimod: Cytokine induction and modifying the immune response to HPV: A new therapy for genital warts Abstract S25-6 The 7th Congress of the European Academy of Dermatology and Venereology, Nice, 7-11 Oct 1998","volume":"11","author":"Jappe","year":"1998","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"9","key":"10.1002\/14651858.CD010389.pub2-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001781.pub3","article-title":"Topical treatments for cutaneous warts","author":"Kwok","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8-9 Pt 1","key":"10.1002\/14651858.CD010389.pub2-BIB0038|cit38","first-page":"731","article-title":"A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France","volume":"130","author":"Lafuma","year":"2003","journal-title":"Annales de Dermatologie et de V\u00e9n\u00e9reologie"},{"issue":"1","key":"10.1002\/14651858.CD010389.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3111\/13696990903451461","article-title":"A cost-effectiveness analysis of sinecatechins in the treatment of external genital warts","volume":"13","author":"Langley Paul","year":"2010","journal-title":"Journal of Medical Economics"},{"issue":"1","key":"10.1002\/14651858.CD010389.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1468-3083.2002.00366.x","article-title":"Imiquimod 5% cream is an acceptable treatment option for external anogenital warts in uncircumcised males","volume":"16","author":"Maw","year":"2002","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1002\/14651858.CD010389.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1258\/095646204774195173","article-title":"Critical appraisal of commonly used treatment for genital warts","volume":"15","author":"Maw","year":"2004","journal-title":"International Journal of STD & AIDS"},{"issue":"3","key":"10.1002\/14651858.CD010389.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"233.e1","DOI":"10.1016\/j.ajog.2008.07.064","article-title":"Green tea catechins for treatment of external genital warts","volume":"200","author":"Meltzer","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0043|cit43","first-page":"S116","article-title":"Significant inflammation is not needed for the clearance of external genital warts by imiquimod. Abstract CP5-8. The 8th Congress of the European Academy of Dermatology and Venereology; 29 Sept-3 Oct 1999; Amsterdam","volume":"12","author":"Miller","year":"1999","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"8","key":"10.1002\/14651858.CD010389.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1463-1318.2009.01960.x","article-title":"Immunostimulation to reduce recurrence after surgery for anal condyloma acuminata: a prospective randomized controlled trial","volume":"12","author":"Mistrangelo","year":"2010","journal-title":"Colorectal Disease"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2334-1-3","article-title":"Imiquimod for the treatment of genital warts: a quantitative systematic review","volume":"1","author":"Moore","year":"2001","journal-title":"BMC Infectious Diseases"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0046|cit46","unstructured":"NCT00114023 1-year follow up to the 1473-IMIQ study http:\/\/clinicaltrials.gov\/show\/NCT00114023"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0047|cit47","unstructured":"NCT00189293 Study of imiquimod cream prior to ablative therapy in external ano-genital warts http:\/\/clinicaltrials.gov\/show\/NCT00189293"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0048|cit48","unstructured":"NCT00674739 Safety and effectiveness study of imiquimod creams in the treatment of external genital warts http:\/\/clinicaltrials.gov\/show\/NCT00674739"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0049|cit49","unstructured":"NCT00735462 Phase 3 study of imiquimod creams in the treatment of external genital warts http:\/\/clinicaltrials.gov\/show\/NCT00735462"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0050|cit50","unstructured":"NCT00941811 Immunevasion of human papillomavirus (HPV) in vulvar intraepithelial neoplasia 2\/3 and anogenital warts and efficiency and mechanisms of imiquimod treatment http:\/\/clinicaltrials.gov\/show\/NCT00941811"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0051|cit51","unstructured":"NCT00979550 The effects of Aldara as an adjunct to laser treatment http:\/\/clinicaltrials.gov\/show\/NCT00979550"},{"issue":"9","key":"10.1002\/14651858.CD010389.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1258\/0956462011923723","article-title":"New patient-applied therapy for anogenital warts is rated favourably by patients","volume":"12","author":"O'Mahony","year":"2001","journal-title":"International Journal of STD & AIDS"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0053|cit53","first-page":"S348","article-title":"Imiquimod 5% cream is effective and safe in the treatment of genital\/perianal warts. Abstract P-725. The 8th Congress of the European Academy of Dermatology and Venereology. 29th Sept-3rd Oct Amsterdam","volume":"12","author":"Owens","year":"1999","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"2","key":"10.1002\/14651858.CD010389.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0253-7184.62763","article-title":"A study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients","volume":"30","author":"Puri","year":"2009","journal-title":"Indian Journal of Sexually Transmitted Diseases"},{"issue":"2","key":"10.1002\/14651858.CD010389.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00007435-200302000-00006","article-title":"Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations","volume":"30","author":"Sauder","year":"2003","journal-title":"Sexually Transmitted Diseases"},{"issue":"12","key":"10.1002\/14651858.CD010389.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1128\/AAC.47.12.3846-3852.2003","article-title":"Randomized, single-blind, placebo-controlled study of topical application of the immune response modulator resiquimod in healthy adults","volume":"47","author":"Sauder","year":"2003","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010389.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2133.2007.08274.x","article-title":"Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies","volume":"157","author":"Sch\u00f6fer","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD010389.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1346-8138.1998.tb02429.x","article-title":"Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study","volume":"25","author":"Syed","year":"1998","journal-title":"Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010389.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/jinf.2000.0709","article-title":"Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study","volume":"41","author":"Syed","year":"2000","journal-title":"Journal of Infection"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0060|cit60","unstructured":"Syed T Imiquimod 5% versus podophyllotoxin 0.5% in cream for the treatment of genital warts. A placebo-controlled, double-blind, comparative study. Abstract 20th World Congress of Dermatology; 2002 July 1-5; Paris"},{"issue":"7 Suppl","key":"10.1002\/14651858.CD010389.pub2-BIB0061|cit61","first-page":"17","article-title":"Imiquimod in clinical practice","volume":"8","author":"Trofatter","year":"1998","journal-title":"European Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010389.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0020-7292(01)00573-2","article-title":"Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women","volume":"76","author":"Trofatter","year":"2002","journal-title":"International Journal of Gynaecology & Obstetrics"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0063|cit63","first-page":"361","article-title":"An open-label comparative study to evaluate the efficacy and tolerability of imiquimod 5% cream alone and combined with cryotherapy in the treatment of recalcitrant anogenital warts. Abstract P14.26. The 14th Congress of the European Academy of Dermatology and Venereology; Oct 12-15 2005; London","volume":"19","author":"Tuncel","year":"2005","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0064|cit64","first-page":"270","article-title":"Two vehicle-controlled clinical trials of topical imiquimod for the treatment of genital\/perianal warts. Abstract 5159. The 19th World Congress of Dermatology; 1997 June 15-20; Sydney","volume":"38","author":"Tyring","year":"1997","journal-title":"Australasian Journal of Dermatology"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"A426","DOI":"10.1016\/S1098-3015(10)75104-4","article-title":"Cost-effectiveness analysis of imiquimod versus podophyllotoxin in treatment of genital\/perianal warts in Poland","volume":"12","author":"Walczak","year":"2009","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"A417","DOI":"10.1016\/S1098-3015(10)75063-4","article-title":"Systematic review of the efficacy and safety of imiquimod 5% cream for the treatment of external genital warts","volume":"12","author":"Walczak","year":"2009","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0067|cit67","first-page":"263","article-title":"Imiquimod 5% cream for the treatment of external anogenital warts: a randomised controlled study","volume":"40","author":"Wang","year":"2007","journal-title":"Chinese Journal of Dermatology"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0068|cit68","unstructured":"Weinberg JM Stewart A Stern JO Imiquimod cream for genital warts American Family Physician 1997 2348"},{"issue":"4","key":"10.1002\/14651858.CD010389.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1258\/095646203321264827","article-title":"The cost-effectiveness of patient-applied treatments for anogenital warts","volume":"14","author":"Williams","year":"2003","journal-title":"International Journal of STD & AIDS"},{"issue":"3","key":"10.1002\/14651858.CD010389.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000095039","article-title":"Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata","volume":"213","author":"Yan","year":"2006","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0071|cit71","unstructured":"CTRI\/2009\/091\/000055 A clinical trial to study the effect of two drugs- Mycobacterium w vaccine and imiquimod in patients with genital warts http:\/\/www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=331"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0029-7844(99)90071-6","article-title":"Imiquimod 5% cream is effective and safe in the treatment of genital\/perianal warts in female patients","volume":"93","author":"Ferenczy","year":"1999","journal-title":"Obstetrics & Gynecology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010389.pub2-BIB0073|cit73","first-page":"AB46","article-title":"Imiquimod 2.5% and 3.75% for the treatment of external genital warts: Assessment of ef\ufb01cacy in 981 randomized patients","volume":"70","author":"Nelson","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD010389.pub2-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006562.pub2","article-title":"5-FU for genital warts in non-immunocompromised individuals","author":"Batista","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010389.pub2-BIB0075|cit75","first-page":"5","article-title":"The role of imiquimod 3.75% cream in the treatment of external genital warts","volume":"17","author":"Berman","year":"2012","journal-title":"Skin Therapy Letter"},{"issue":"2","key":"10.1002\/14651858.CD010389.pub2-BIB0076|cit76","first-page":"49","article-title":"Imiquimod (Aldara cream)","volume":"6","author":"Buck","year":"1998","journal-title":"Infectious Diseases in Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD010389.pub2-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007993","article-title":"Interferon for anogenital warts in non-immunocompromised adults","author":"Chen","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010389.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jac\/48.6.751","article-title":"Imiquimod and resiquimod as novel immunomodulators","volume":"48","author":"Dockrell","year":"2001","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"7109","key":"10.1002\/14651858.CD010389.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"3","key":"10.1002\/14651858.CD010389.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/00313020212469","article-title":"Human papillomavirus update with a particular focus on cervical disease","volume":"34","author":"Garland","year":"2002","journal-title":"Pathology"},{"issue":"4","key":"10.1002\/14651858.CD010389.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"310","DOI":"10.18597\/rcog.395","article-title":"Molecular aspects of human papillomavirus and cervical cancer","volume":"59","author":"Grillo-Ardila","year":"2008","journal-title":"Revista Colombiana de Obstetricia y Ginecolog\u00eda"},{"issue":"20","key":"10.1002\/14651858.CD010389.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0083|cit83","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from\u00a0www.cochrane-handbook.org"},{"issue":"7","key":"10.1002\/14651858.CD010389.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD010389.pub2-BIB0085|cit85","first-page":"2335","article-title":"Management of genital warts","volume":"70","author":"Kodner","year":"2004","journal-title":"American Family Physician"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010389.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-4632.2002.00016.x","article-title":"Imiquimod 5% cream: a topical immune response modifier","volume":"41","author":"Marini","year":"2002","journal-title":"International Journal of Dermatology"},{"issue":"7266","key":"10.1002\/14651858.CD010389.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/bmj.321.7266.910","article-title":"The management of anogenital [correction of anal] warts","volume":"321","author":"Maw","year":"2000","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"3","key":"10.1002\/14651858.CD010389.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/LGT.0b013e31815dd4b4","article-title":"Modern management of external genital warts","volume":"12","author":"Mayeaux","year":"2008","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"1","key":"10.1002\/14651858.CD010389.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0192-0561(98)00068-X","article-title":"Imiquimod applied topically: a novel immune response modifier and new class of drug","volume":"21","author":"Miller","year":"1999","journal-title":"International Journal of Immunopharmacology"},{"key":"10.1002\/14651858.CD010389.pub2-BIB0090|cit90","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"6","key":"10.1002\/14651858.CD010389.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2174\/092986707780059625","article-title":"The antitumoural mode of action of imiquimod and other imidazoquinolines","volume":"14","author":"Sch\u00f6n","year":"2007","journal-title":"Current Medicinal Chemistry"},{"issue":"6","key":"10.1002\/14651858.CD010389.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1517\/14712598.2012.676036","article-title":"The use of sinecatechins (polyphenon E) ointment for treatment of external genital warts","volume":"12","author":"Stockfleth","year":"2012","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"3","key":"10.1002\/14651858.CD010389.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/sti.76.3.162","article-title":"European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts","volume":"76","author":"Krogh","year":"2000","journal-title":"Sexually Transmitted Infections"},{"issue":"15","key":"10.1002\/14651858.CD010389.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2165\/00003495-200767150-00006","article-title":"Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions","volume":"67","author":"Wagstaff","year":"2007","journal-title":"Drugs"},{"issue":"1","key":"10.1002\/14651858.CD010389.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/3600604","article-title":"Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000","volume":"36","author":"Weinstock","year":"2004","journal-title":"Perspectives on Sexual and Reproductive Health"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010389.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/342109","article-title":"External genital warts: diagnosis, treatment, and prevention","volume":"35","author":"Wiley","year":"2002","journal-title":"Clinical Infectious Diseases"},{"issue":"RR-12","key":"10.1002\/14651858.CD010389.pub2-BIB0097|cit97","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010","volume":"59","author":"Workowski","year":"2010","journal-title":"MMWR Recommended Reports"},{"issue":"2","key":"10.1002\/14651858.CD010389.pub2-BIB0098|cit98","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010389","article-title":"Imiquimod for anogenital warts in non-immunocompromised adults","author":"Grillo-Ardila","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010389.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T09:32:38Z","timestamp":1704879158000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010389.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane STI Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,1]]},"references-count":98,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010389.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,1]]}}}